News By Tag Industry News News By Location Country(s) Industry News
| Carlson VC: Nutrix AG advances launch of cortiSense – award-winning cortisol monitoring techUse of Proceeds and Development Plans With the support of Carlson Investments SE and other strategic investors, Nutrix AG has raised USD 4 million to date. The company is advancing the commercialization of cortiSense and expanding its presence in international markets. Nutrix currently holds operational presence in Switzerland, Poland, Chile, Mexico, and Peru, with plans for further expansion into the U.S. and Japanese markets. Current development efforts are focused on:
About Nutrix AG Nutrix AG is a Swiss healthcare company developing AI-based solutions for non-invasive health monitoring. Originally focused on glucose detection in saliva to support diabetes management, Nutrix aims to help users prevent and manage chronic conditions through accessible, painless tracking methods. About Carlson Investments SE Carlson Investments SE, listed on Warsaw's NewConnect and the German Open Market (Frankfurt, Munich, Stuttgart, Gettex), supports high-growth early-stage tech ventures across healthtech, AI, fintech, and deeptech. Carlson applies a hands-on investment approach and integrates its portfolio companies into a global network of strategic partnerships. Risk Disclaimer This announcement • does not constitute investment advice or a solicitation to buy or sell financial instruments • involves risks, including possible loss of capital • does not guarantee future earnings • past performance is not indicative of future results. WE ARE PUBLICLY LISTED, YOU CAN BUY OUR SHARES ON: Warsaw Stock Exchange (PLN): CAI, PLHOTB000011 Frankfurt Stock Exchange (EUR): 2HB (FRA), PLHOTB000011 Munich Stock Exchange (EUR): 2HB (MUN), PLHOTB000011 Stuttgart Stock Exchange (EUR): 2HB (STU), PLHOTB000011 GETTEX Exchange (EUR): 2HB (GET), PLHOTB000011 WKN: A0RNWQ Press Contact: Management Office Carlson Investments SE ir@carlsonvc.com https://carlsonvc.com/ End
|
|